π Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Alembic Pharma Receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion
Alembic Pharmaceuticals has secured final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%, which is a generic version of Sandoz's Durezol. The product is used for treating inflammation and pain after ocular surgery and for endogenous anterior uveitis. This approval marks a continued expansion of the company's US product portfolio. With this addition, Alembic now holds a cumulative total of 233 USFDA approvals, including 213 final approvals.
Key Highlights
Received final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%
Product is therapeutically equivalent to the reference listed drug Durezol by Sandoz Inc.
Indicated for ocular surgery inflammation and endogenous anterior uveitis
Company's cumulative USFDA approvals reach 233 (213 final and 20 tentative)
πΌ Action for Investors
Investors should monitor the commercial launch and market share capture of this product in the US ophthalmic market. The steady stream of USFDA approvals remains a key driver for the company's international revenue growth.
Raymond Board Approves Merger of Wholly Owned Subsidiary Everblue Apparel Limited
Raymond Limited's Board has approved the amalgamation of its wholly-owned subsidiary, Everblue Apparel Limited (EBAL), into the parent company. EBAL, which focuses on converting denim fabrics into readymade garments, reported a turnover of βΉ108.58 crore and a net worth of βΉ3.76 crore as of December 31, 2025. As EBAL is a 100% subsidiary, no new shares will be issued, resulting in zero equity dilution for Raymond's shareholders. The merger is intended to simplify the group structure, achieve operational synergies, and reduce administrative costs.
Key Highlights
Amalgamation of 100% subsidiary Everblue Apparel Limited (EBAL) into Raymond Limited approved.
EBAL reported a turnover of βΉ10,858 Lakhs and a net worth of βΉ376 Lakhs as of December 31, 2025.
No cash consideration or share exchange; EBAL's entire share capital will be cancelled upon merger.
The merger aims to integrate garmenting operations directly into Raymond for better management focus.
The scheme is subject to approvals from NCLT, shareholders, and creditors.
πΌ Action for Investors
Investors should view this as a positive move toward corporate simplification and cost rationalization. Since there is no equity dilution, the focus remains on the operational efficiencies gained from the integration.
IRFC Q3 FY26: AUM Hits βΉ4.75 Lakh Cr, Targets βΉ8 Lakh Cr by 2030 with 3x Higher Margins
IRFC reported a strong Q3 FY26, with Assets Under Management (AUM) growing to βΉ4.75 lakh crore and a clear roadmap to reach βΉ8 lakh crore by 2030. The company is successfully diversifying into the broader railway ecosystem, where new assets offer margins 2x to 3x higher than traditional lending to Indian Railways. Management has already surpassed its annual sanction guidance and achieved 75% of its βΉ30,000 crore disbursement target for the year. Despite new RBI-mandated standard asset provisioning of βΉ50 crore, the company maintains a zero NPA status and expects consistent growth in PAT and NIM.
Key Highlights
AUM increased to βΉ4.75 lakh crore in Q3 FY26, with a near-term target to exceed βΉ5 lakh crore.
New non-railway ecosystem projects are yielding margins of 100-120 bps, compared to the traditional 40 bps from Indian Railways.
The 2030 vision targets a 60-40 portfolio mix between Indian Railways and the wider railway ecosystem to boost overall yields.
Achieved 75% of the βΉ30,000 crore annual disbursement target and surpassed the annual asset sanction guidance.
Maintained zero NPAs while successfully raising low-cost funds via Yen-denominated ECBs and zero-coupon bonds.
πΌ Action for Investors
Investors should focus on the successful transition to 'IRFC 2.0' which prioritizes higher-margin ecosystem lending over traditional low-spread railway financing. The stock remains a strong long-term play due to its zero-NPA status and sovereign-backed growth trajectory.
Raymond Q3 FY26: Continuing Operations Post Net Loss of βΉ3.24 Cr Following Major Demergers
Raymond Limited reported a net loss of βΉ3.24 crore from continuing operations for the quarter ended December 31, 2025, a sharp decline from a profit of βΉ9.28 crore in the year-ago period. Revenue from continuing operations fell to βΉ18.19 crore compared to βΉ22.89 crore in Q3 FY25. The financial profile of the company has fundamentally changed following the demerger of its Lifestyle and Real Estate businesses into separate entities. The current results reflect the performance of the residual 'stub' entity post-restructuring.
Key Highlights
Revenue from continuing operations declined 20.5% YoY to βΉ18.19 crore in Q3 FY26.
Net loss for the quarter stood at βΉ3.24 crore versus a profit of βΉ9.28 crore in Q3 FY25.
Total Comprehensive Loss widened to βΉ40.80 crore, largely due to a βΉ44.05 crore loss in fair value of equity instruments.
The Real Estate business demerger was completed with an effective date of May 1, 2025.
Basic EPS for continuing operations turned negative at βΉ(0.49) for the quarter.
πΌ Action for Investors
Investors should note that Raymond Limited is now a residual entity as the primary value drivers (Lifestyle and Realty) have been demerged. Future valuation will depend on the remaining engineering/industrial businesses and the value of its holdings in the newly formed entities.
UPL to Announce Q3 FY2026 Results on February 2, 2026
UPL Limited has scheduled a Board of Directors meeting on February 2, 2026, to approve the unaudited financial results for the quarter and nine-month period ended December 31, 2025. An earnings conference call will follow the board meeting at 16:00 hrs IST on the same day to discuss the company's performance. The trading window for designated persons has been closed since December 31, 2025, and will remain so until 48 hours after the results are made public. This is a routine regulatory announcement ahead of the quarterly earnings release.
Key Highlights
Board meeting scheduled for February 2, 2026, to approve Q3 and 9M FY2026 results
Earnings conference call to be held at 16:00 hrs IST on February 2, 2026
Trading window remains closed from December 31, 2025, until 48 hours post-results
UPL operates globally with annual revenue exceeding $5 billion
πΌ Action for Investors
Investors should monitor the upcoming results on February 2 for updates on global agrochemical demand and the company's debt management. No immediate action is required as this is a routine scheduling notification.
Dynamic Cables Q3 FY26 Net Profit Jumps 41.9% YoY to βΉ22.42 Crore
Dynamic Cables Limited (DYCL) reported a robust performance for the quarter ended December 31, 2025, with revenue from operations growing 18.8% YoY to βΉ298.77 crore. Net profit for the quarter surged by 41.9% YoY to βΉ22.42 crore, up from βΉ15.80 crore in the same period last year. For the nine-month period (9M FY26), the company's net profit reached βΉ60.27 crore, representing a significant 46% growth compared to 9M FY25. The company has also successfully utilized βΉ84.88 crore from its preferential issue proceeds for business objectives.
Key Highlights
Revenue from operations increased 18.8% YoY to βΉ29,876.77 Lakhs in Q3 FY26.
Net Profit for the quarter rose 41.9% YoY to βΉ2,242.27 Lakhs.
9M FY26 Net Profit grew by 46% YoY to βΉ6,026.53 Lakhs compared to βΉ4,125.59 Lakhs in 9M FY25.
Basic and Diluted EPS for the quarter improved to βΉ4.63 from βΉ3.26 YoY (adjusted for 1:1 bonus issue).
Company utilized βΉ84.88 Crore of the βΉ96.59 Crore raised via preferential issue for growth objectives.
πΌ Action for Investors
The strong double-digit growth in both revenue and profitability indicates healthy demand and operational efficiency. Investors should maintain a positive outlook while monitoring the company's ability to maintain these margins in a competitive cable industry.
PFS Seeks Shareholder Approval for Appointment of P. Ramana Murthy as Independent Director
PTC India Financial Services (PFS) has issued a postal ballot notice to seek shareholder approval for the appointment of Shri Pikkili Ramana Murthy as an Independent Director. Mr. Murthy was previously appointed as an Additional Director on December 19, 2025, and the company is now proposing a formal 3-year tenure. The voting process will be conducted via remote e-voting, with the eligibility determined by a cut-off date of January 21, 2026. Results of the resolution are expected to be declared by March 1, 2026.
Key Highlights
Appointment of Shri Pikkili Ramana Murthy as an Independent Director for a 3-year term.
The tenure is effective from December 19, 2025, subject to shareholder approval via Special Resolution.
Remote e-voting period is scheduled from January 28, 2026, to February 26, 2026.
Cut-off date for determining shareholder voting eligibility was January 21, 2026.
Final results of the postal ballot will be announced on or before March 1, 2026.
πΌ Action for Investors
This is a routine corporate governance matter; shareholders should review the director's credentials in the explanatory statement and cast their votes during the specified window.
Aurionpro Wins Multi-Million Dollar Mumbai Metro Line 5 Order for Platform Screen Door Systems
Aurionpro Solutions has secured a significant multi-year, multi-million-dollar contract from Titagarh Rail Systems for Mumbai Metro Line 5. This order marks the company's strategic entry into the safety-critical Platform Screen Door (PSD) market, expanding its total addressable market in the smart transit sector. The project, involving design, supply, and long-term maintenance, will be executed in consortium with KTK Group. This win further consolidates Aurionpro's presence in the Mumbai metro ecosystem, following previous successes with Lines 4 and 4A.
Key Highlights
Secured a multi-million-dollar order from Titagarh Rail Systems for Mumbai Metro Line 5.
Marks entry into the Automatic Platform Screen Door (PSD) market, a new high-tech segment for the company.
Project includes design, supply, commissioning, and long-term maintenance in consortium with KTK Group.
Manufacturing will be supported by the company's Ghaziabad facility under the 'Make in India' initiative.
Strengthens the company's urban mobility portfolio, which already includes Mumbai Metro Lines 4 and 4A.
πΌ Action for Investors
Investors should view this as a strong positive as it demonstrates Aurionpro's ability to diversify its high-tech offerings and secure large-scale infrastructure orders. Monitor the execution of this multi-year contract for its contribution to long-term revenue visibility and margin improvement.
Neuland Labs to Report Q3 FY26 Results and Host Earnings Call on February 09, 2026
Neuland Laboratories Limited has scheduled the announcement of its financial results for the third quarter and nine months ended December 31, 2025, for February 09, 2026. Following the board's approval, the management will host a conference call at 17:30 IST to discuss the company's performance. The company continues to leverage its portfolio of over 100 APIs and 73 active US DMFs across 80 countries. This call will provide critical updates on the company's manufacturing and regulatory progress.
Key Highlights
Q3 FY2026 results and earnings call scheduled for February 09, 2026, at 17:30 IST
Company manages a portfolio of 100+ APIs and has filed 995+ regulatory documents globally
Maintains 73 active US Drug Master Files (DMFs) with facilities certified by US FDA and EDQM
Operational presence spans across approximately 80 countries with 300+ developed processes
πΌ Action for Investors
Investors should monitor the upcoming results for growth in the CMS segment and margin sustainability. No immediate action is required until the financial data is released on February 09.
MTAR Technologies to Host Q3 & 9MFY26 Earnings Call on January 30, 2026
MTAR Technologies has scheduled its earnings conference call for the third quarter and nine months ended December 31, 2025. The call is slated for Friday, January 30, 2026, at 11:00 AM IST to discuss the company's operational and financial performance. Key management, including Managing Director Srinivas Reddy and CFO Gunneswara Rao Pusarla, will be in attendance. This meeting provides a platform for institutional investors and analysts to gain insights into the company's recent growth trajectory.
Key Highlights
Earnings call scheduled for January 30, 2026, at 11:00 AM IST.
Covers financial results for the quarter and nine-month period ending December 31, 2025.
Management representation includes the Managing Director, CFO, and Head of Strategy.
Primary domestic dial-in numbers are +91 22 6280 1550 and +91 22 7115 8378.
International toll-free access available for Hong Kong, Singapore, USA, and UK.
πΌ Action for Investors
Investors should attend or review the transcript of the call to understand the company's order book status and execution timelines. No immediate trading action is required based on this routine scheduling announcement.
IEX Reschedules Q3 FY26 Earnings Conference Call to 4:00 PM on January 30, 2026
Indian Energy Exchange (IEX) has announced a revision in the timing of its conference call to discuss financial results for the quarter ended December 2025 (Q3 FY26). The call, originally scheduled for 02:30 PM IST on January 30, 2026, will now be held at 04:00 PM IST on the same day. The session will feature a management discussion on earnings performance followed by an interactive Q&A. Key leadership including the Chairman and Managing Director will be present to address investor queries.
Key Highlights
Conference call rescheduled for Friday, January 30, 2026, at 04:00 PM IST
Previous timing for the call was 02:30 PM IST on the same date
Call will cover financial results for the quarter ended December 2025
Management representation includes CMD Mr. Satyanarayan Goel and CFO Mr. Vineet Harlalka
πΌ Action for Investors
Investors and analysts should update their schedules for the new 04:00 PM IST time slot to hear management's commentary on Q3 performance. No fundamental change to the company's outlook is implied by this scheduling update.
Gravita India Q3 FY26: PAT Jumps 32% YoY to βΉ97.67 Cr Despite Flat Revenue
Gravita India reported a strong 32% YoY increase in PAT to βΉ97.67 crores for Q3 FY26, driven by improved margins and operational efficiencies despite flat revenue of βΉ1,017 crores. The company faced temporary delays in capacity expansion at Mundra and Jaipur due to licensing formalities, but expects commissioning in Q4 FY2026. Management maintained a positive outlook with Lead EBITDA at βΉ23,000 per MT and a long-term target to reach 7 lakh MTPA capacity by FY2028. Additionally, the company increased its stake in Gravita Europe to 95%, further strengthening its international recycling platform.
Key Highlights
PAT grew 32% YoY to βΉ97.67 crores with PAT margins improving to 9.60%.
Adjusted EBITDA rose 13% YoY to βΉ116 crores, supported by strong Lead EBITDA of βΉ23,000 per MT.
Plastic segment volumes rebounded significantly, increasing 55% QoQ to 3,160 metric tonnes.
Mundra (80,000 MTPA) and Jaipur (45,000 MTPA) lead capacity expansions are slated for Q4 FY2026 completion.
Vision 2029 targets include a volume CAGR of over 25% and ROIC exceeding 25%.
πΌ Action for Investors
Investors should monitor the timely commissioning of the Mundra and Jaipur facilities in Q4, as these will be key drivers for volume growth in FY2027. The company's ability to maintain high margins despite flat revenue suggests strong pricing power and efficient scrap sourcing.
Medico Remedies Bags βΉ37.18 Crore Order from UP Medical Supplies Corporation
Medico Remedies Limited has secured a significant domestic supply order worth approximately βΉ37.18 crore from the Uttar Pradesh Medical Supplies Corporation Limited. The contract involves the supply of multiple drugs to the Government of Uttar Pradesh's centralized distribution entity. The company is expected to complete the full supply of the order by October 31, 2026. This government contract provides strong revenue visibility for the company over the next 20 months.
Key Highlights
Total order value is βΉ37,17,62,439 (approximately βΉ37.18 crore)
Contract awarded by Uttar Pradesh Medical Supplies Corporation Limited, a GoUP entity
The order involves the supply of multiple drugs for state-wide distribution
Project completion timeline is set for October 31, 2026
πΌ Action for Investors
Investors should view this as a positive development for revenue growth and monitor the company's ability to maintain margins on government-tendered contracts. Watch for timely execution updates as the October 2026 deadline approaches.
Raymond Lifestyle Appoints Prasad Ellatch Chathuar as CFO; 28 Years Experience
Raymond Lifestyle Limited has appointed Mr. Prasad Ellatch Chathuar as the Chief Financial Officer effective January 27, 2026. He succeeds Mr. Vishal Raigagla, who had been serving as the Interim CFO since October 29, 2025. Mr. Chathuar is a seasoned professional with 28 years of experience in the consumer industry, including a previous role as CFO at Bajaj Electricals Limited. This transition from an interim to a permanent, highly qualified CFO is expected to provide long-term stability to the company's financial leadership.
Key Highlights
Mr. Prasad Ellatch Chathuar appointed as CFO and Key Managerial Personnel effective January 27, 2026.
Brings 28 years of experience from Bajaj Electricals, Voltas (17 years), and Emami Paper Mills (5 years).
Replaces Interim CFO Vishal Raigagla, who held the position since October 29, 2025.
Educational qualifications include Chartered Accountant, Cost Accountant, and a Harvard University Executive Certification.
πΌ Action for Investors
The appointment of a permanent CFO with significant industry experience is a positive development for corporate governance. Investors should view this as a stabilizing move for the company's financial strategy and execution.
HILINFRA Commences Toll Operations at Kaza Plaza; Order Book Reaches βΉ1,209 Cr
Highway Infrastructure Limited (HIL) has commenced toll operations at the Kaza Fee Plaza on NH-16, marking its largest-ever single toll mandate valued at βΉ328.77 crore. The Kaza Plaza is a high-traffic corridor and is recognized as the highest-earning public-funded toll plaza in South India, generating approximately βΉ27 crore in monthly collections. This commencement has significantly boosted the company's total order book to βΉ1,209 crore, with the tollways segment growing by 404% since March 2025. The project follows an asset-light model, ensuring immediate revenue generation and improved cash flow visibility for the next year.
Key Highlights
Commenced βΉ328.77 crore toll operations contract at Kaza Fee Plaza, the largest in company history.
Total consolidated order book strengthened to βΉ1,209 crore as of January 2026.
Tollways collection order book grew by ~404% from βΉ114 crore in March 2025 to βΉ575 crore.
EPC order book increased by 52% during the same period, reaching βΉ633 crore.
Kaza Plaza generates the highest monthly toll in South India at approximately βΉ27 crore.
πΌ Action for Investors
Investors should monitor the company's execution efficiency and the impact of this high-value contract on upcoming quarterly earnings. The significant 404% growth in the tolling order book suggests a strong shift toward high-cash-flow operational revenue.
MEP Infrastructure Conducts 21st CoC Meeting Amid Ongoing Insolvency Process
MEP Infrastructure Developers Limited held its 21st Committee of Creditors (CoC) meeting on January 23, 2026, as part of its ongoing insolvency proceedings. The company has been under the Corporate Insolvency Resolution Process (CIRP) since March 28, 2024, following an order by the Honβble NCLT. A moratorium under Section 14 of the IBC is currently in effect, and the process is being managed by Resolution Professional Ravindra Kumar Goyal. This meeting is a continuation of the efforts to reach a resolution for the company's outstanding debts.
Key Highlights
21st CoC meeting convened on January 23, 2026, to discuss resolution progress.
Company has been under CIRP for approximately 22 months since the March 2024 NCLT order.
Moratorium under Section 14 of the Insolvency and Bankruptcy Code, 2016, remains active.
Resolution Professional (RP) Ravindra Kumar Goyal continues to oversee the company's affairs.
πΌ Action for Investors
Equity shareholders should be aware that insolvency proceedings typically result in significant capital loss or total wipeout. Avoid fresh positions until a clear resolution plan is approved and its impact on equity is disclosed.
Aster DM Healthcare to Host Q3 FY26 Earnings Conference Call on February 2, 2026
Aster DM Healthcare Limited has scheduled its earnings conference call for Monday, February 2, 2026, at 11:00 AM IST. The call will discuss the unaudited financial results for the third quarter and nine-month period ended December 31, 2025. Senior leadership, including Chairman Dr. Azad Moopen and Deputy MD Alisha Moopen, will be present to address investor queries. This is a standard regulatory disclosure under SEBI (LODR) Regulations, 2015.
Key Highlights
Earnings conference call scheduled for February 2, 2026, at 11:00 AM IST.
Discussion will cover financial performance for Q3 and the nine months ended December 31, 2025.
Top management including CMD, Deputy MD, and CFO will participate in the call.
The announcement is a routine compliance filing under SEBI Regulation 30.
πΌ Action for Investors
Investors should attend the call to understand management's outlook on hospital occupancy and expansion strategy. No immediate action is required as this is a routine scheduling announcement.
Raymond Lifestyle Appoints Prasad Ellatch Chathuar as CFO; Succeeds Interim CFO
Raymond Lifestyle Limited has appointed Mr. Prasad Ellatch Chathuar as its permanent Chief Financial Officer, effective January 27, 2026. He replaces Mr. Vishal Raigagla, who had been serving as the Interim CFO since October 29, 2025. Mr. Chathuar brings 28 years of extensive experience in the consumer industry, having previously served as the CFO of Bajaj Electricals Limited and holding senior roles at Voltas for 17 years. This transition from interim to permanent leadership marks a significant step in stabilizing the management of the newly listed entity.
Key Highlights
Mr. Prasad Ellatch Chathuar appointed as CFO and Key Managerial Personnel effective January 27, 2026.
The new CFO brings 28 years of experience, including a prior CFO role at Bajaj Electricals and 17 years at Voltas.
Mr. Vishal Raigagla ceases to be the Interim CFO after serving in the role since October 2025.
Mr. Chathuar is a Chartered Accountant and Cost Accountant with an Executive Certification in Finance from Harvard University.
πΌ Action for Investors
Investors should view the appointment of a highly experienced permanent CFO as a positive move for corporate governance and financial strategy. Monitor the company's upcoming financial disclosures for any shifts in capital allocation or business transformation strategies under the new leadership.
WeWork India Q3 FY26: PAT Surges 511% YoY to βΉ52 Cr; Revenue Hits Record βΉ640 Cr
WeWork India reported a record-breaking Q3 FY26 with total revenue reaching βΉ640.3 crore, a 27% YoY increase. Profitability saw a massive jump as PAT rose 511.8% YoY to βΉ52 crore, driven by operational leverage and high occupancy levels of 83.9%. The company demonstrated strong capital efficiency with ROCE improving to 32.6% and a low Net Debt to EBITDA ratio of 0.25x. The Managed Office segment and GCC demand remain key growth drivers, with a future supply pipeline of 11.4 million square feet already in place.
Key Highlights
Quarterly Revenue grew 27% YoY to βΉ640.3 crore with EBITDA margins expanding to 21.0%
PAT witnessed an exponential growth of 511.8% YoY to βΉ52 crore excluding exceptional items
Operational desk capacity increased to 121.6k across 73 centres in 8 cities with 83.9% occupancy
Return on Capital Employed (ROCE) improved significantly to 32.6% from 17.3% a year ago
Operating cash flows stood at βΉ203.8 crore, representing a strong 1.5x EBITDA conversion
πΌ Action for Investors
The company is demonstrating strong structural profitability and efficient capital deployment, making it a compelling play on the flex-office trend in India. Investors should monitor the execution of the 11.4 MSF supply pipeline and continued adoption by Global Capability Centers (GCCs).
63 moons Launches Upgraded Trading Engine for MSE Equity Cash Segment
63 moons technologies limited has announced that the Metropolitan Stock Exchange of India Limited (MSE) is launching its Equity Cash Segment using an upgraded trading engine provided by the company. This deployment, effective from January 27, 2026, follows a technology services model similar to the one 63 moons has provided to MCX since 2003. The move marks a significant milestone in the company's exchange technology business and reinforces its position as a key infrastructure provider. This partnership highlights the company's ability to maintain and upgrade critical financial market systems.
Key Highlights
MSE launches Equity Cash Segment trading with 63 moons' upgraded engine on Jan 27, 2026
The technology services model is based on the successful framework provided to MCX since 2003
Deployment validates the company's core technology stack and exchange solutions capabilities
Strengthens 63 moons' footprint in the Indian financial markets infrastructure space
πΌ Action for Investors
Investors should monitor the revenue contribution from this MSE partnership and look for further client acquisitions in the exchange technology space. The stock may see positive sentiment as this validates their technical expertise following past regulatory challenges.